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ANOREXIA NERVOSA: CURRENT RESEARCH FROM A BIOLOGICAL 
PERSPECTIVE 
Udy Tropp 
ABSTRACT 
Eating disorders are viewed as serious mental illnesses, carrying significant, life-threatening 
medical and psychiatric implications, including morbidity and mortality.  According to the Academy of 
Eating Disorders, anorexia nervosa has the highest mortality rate of any psychiatric disorder. The 
American Psychiatric Association (2004) claims that approximately three percent of the United States 
female population has a clinically relevant eating disorder. Risk of premature death is 6-12 times higher 
in women with anorexia as compared to the general population, and it has become the third most 
common form of chronic illness among adolescent women aged 15 to 19 years. Although the 
prevalence and seriousness of this problem have gained increasing attention in recent years, relatively 
little is known about the role that leptin plays in this disorder. Leptin is a starvation hormone as well as 
a satiety hormone that plays a role in the diagnoses, duration, and recovery of this devastating disease. 
The review of the research will attempt to define the etiology of the endocrine events and the 
significant physiological impact on the body’s structures relative to this disease. The diagnosis and 
treatment will address and reflect the physiological effects caused by the semi-starvation state produced 
by anorexia nervosa.  Anorexia is triggered by psychological problems that transform into biological 
issues.  Profound physiological changes brought about by the semi starvation state cause a domino 
effect.  The biological ramifications of the disease should be cured before psychological counseling is 
attempted. 
INTRODUCTION 
Diagnosable eating disorders, such as anorexia nervosa, are not uncommon, occurring in 
approximately three percent of the United States female population (American Psychiatric Association 
[APA] 2004). According to the Academy for Eating Disorders (2011), eating disorders have become 
the third most common form of chronic illness among adolescent women aged 15 to 19 years. Anorexia 
Nervosa (AN) is classified in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) as 
refusal to maintain a minimally normal body weight (i.e. below 85% medically ideal body weight), 
profound fear of weight gain, body image disturbance, and amenorrhea (i.e. absence of menses) 
(American Psychiatric Association 2004). According to the American Psychiatric Association, anorexia 
nervosa has the highest mortality rate of any psychiatric disorder (Yager, 2000).  Even when feeling 
hungry, afflicted individuals severely limit their food intake based on their irrational fear of gaining 
weight, due to the distorted perception they have of their body as perpetually being overweight. Despite 
their dwindling weight, those suffering from anorexia nervosa will always see themselves as fat. It is 
because of their skewed self-image and irrational fear of obesity that anorexia nervosa is considered a 
disease that is psychiatric in nature. 
HISTORY OF TREATMENT AND PERCEPTION OF ANOREXIA NERVOSA 
Anorexia nervosa is not a new phenomenon. Although the disease did not receive its name until 
recently, its classic symptoms have been around of centuries. Recorded cases of symptoms that appear 
to be the disorder first appear in 1689.  Two case studies by Dr. Richard Morton illustrate that although 
the symptoms and effects were physical, physicians usually treated the patients as if it was a purely 
psychological disorder.  This often led to disastrous and, at times, fatal results. The first case Morton 
presents is that of a young woman who exhibited extreme weight loss, distorted self-image, and loss of 
menarche (three of the four of the current criteria for anorexia nervosa in the DSM-IV (APA 2004). It 
was recorded that the patient’s flesh was flaccid and loose and extremely pale. However, Dr. Morton 
framed the problem as stemming from “a multitude of cares and passions of her mind.” Dr. Morton 
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concluded that it was a psychological disorder, that she could be as “different” as she wanted to be, and 
that this is not a doctor’s area of expertise. The young woman died two months later. In another case, a 
young man displayed similar symptoms. Here too, Dr. Morton concluded that the young man was 
suffering from “passions of the mind” and prescribed some rest and relaxation in the countryside. The 
young man died shortly thereafter (Kendall 2011). 
These cases constitute just two of many that illustrate how physicians in the past ignored the 
biological symptoms and effects of the disease. Any psychological condition was dismissed as one 
having a weak mind or lack of strength, and thus untreatable. No attempts were made to understand the 
harrowing condition.  It was not until the late ninteenth century that anorexia nervosa was to be widely 
accepted by the medical profession as a recognized condition. In 1873, Sir William Gull, one of Queen 
Victoria’s personal physicians, published a seminal paper which established the term anorexia nervosa 
and provided a number of detailed case descriptions and treatments. In the same year, French physician 
Ernest-Charles Lasègue similarly published details of a number of cases in a paper entitled De 
l’Anorexie Histerique. The physicians began to hospitalize and attempt to stabilize the patients 
physiologically. 
During the late twentieth century, the disorder became classified as a purely psychological 
disease. By the time most patients were diagnosed, they were already close to death.  More were 
forcefully hospitalized and received psychiatric treatment.  This method of therapy has been largely 
ineffective at helping individuals suffering from the disease in recovering long-term. Perhaps the 
strongest proof of this is that anorexia nervosa has the highest mortality rate of all psychiatric 
conditions. Long-term data indicate that the mortality rate is 5-10 percent, with only 50 percent of 
patients regaining their normal weight (Mehler et al. 1999). 
This paper will focus on an alternative to a purely psychological approach by concentrating on a 
biological perspective. The diagnosis and treatment will address and reflect various physiological 
ramifications caused by the semi-starvation state produced by anorexia nervosa, signaled by 
hypoleptimia. 
METHODS 
The materials used in this research paper included the Anatomy and Physiology and Biological 
Psychology course textbooks.  Further, the author utilized the Touro College library search engine and 
retrieved journal articles from EBSCO as well as Google and Google Scholar to find basic information 
and peer reviewed articles on the topic. 
DISCUSSION 
There are four criteria that must be satisfied to be considered anorexia by the DSM-IV (APA 
2004).  Two of these criteria are psychiatric conditions: distorted body image and the irrational fear of 
gaining weight and/or becoming fat. The other two are biological concerns brought about by the first 
two factors. Body Mass Index, calculated from a person's weight and height, provides a reliable 
indicator of body fat. For most people, it is used to screen for weight categories that may lead to health 
problems (Centers for Disease Control and Prevention 2011). The third criterion is refusal to maintain a 
weight of at least 85 percent of that expected for height. This can be translated into the fifth-tenth body 
mass index percentile. Figuring for body mass index, as opposed to merely weight, is vital because 
weight alone does not tell the full picture. If someone is five feet one inch and 105 pounds, the 
individual is not underweight. If someone is five feet eleven inches, the individual is severely 
underweight at 105 pounds. “Adults should normally have a body mass index between 18.5 and 24.9… 
a body mass index of under 17.5 is indicative of anorexia nervosa” (Blows 2011). A body mass index 
below 17.5 means the body is now in a semi-starvation mode.  It is scrambling to survive and will use 
and conserve whatever physiological reserves it possesses in order to remain alive and functioning.  
There is a cascading effect of short-term and long-term physical effects in the body. One of the effects 
is amenorrhea. Amenorrhea is the absence of a menstrual period in a woman of reproductive age. The 
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presence of amenorrhea is the fourth criterion, and it is purely physical and biological. The fact that a 
state that can only exist in women is one of the four criteria for anorexia is telling. Psychologically, 
there are many reasons why, according to the National Association of Anorexia Nervosa and 
Associated Disorders (2013), approximately 90-95 percent of anorexia patients are women. Because 
their fat distribution is higher, women’s systems rely on leptin levels more heavily than men. Women, 
having higher leptin levels than men, are thus more susceptible, because when leptin levels are 
lowered, the effects are more rapidly and radically felt by women. 
The point at which the disorder transforms from a purely psychiatric issue into a biological one 
is complex. Acute calorie deprivation for 2-3 days results in a significant decrease in leptin 
concentration before major changes in bodyweight or fat mass go up 20-30 percent (Chan et al. 2005). 
Thus, the body’s leptin levels are significant. It begins when the caloric intake is decreased so much as 
to decrease the resting energy expenditure, also known as resting metabolic rate. This represents the 
amount of calories required in a 24-hour period by the body during a non-active period. At what point 
is the body considered to have entered the semi starvation state? The consensus seems to be that when a 
person decreases the total caloric intake of less than 50 percent of what the body requires, a semi 
starvation mode ensues. The metabolic rate is significantly lowered and begins to make significant 
changes in the body’s functions. These adaptations are controlled processes involving apoptotic 
shutdown and organ hypotrophy that can delay death. In the early stages of malnutrition, there is scope 
for tightening the efficiency of various metabolic functions and for closing down some that are non-
essential in the short term (e.g. reproduction).  As the malnutrition worsens, long-term decisions must 
be made by the body to keep the individual alive. Before all those changes can be made, the resting 
energy expenditure must drop. What tells the metabolic rate that there is not enough caloric intake to 
survive and it must begin to make changes? What acts as the peripheral signal to change the body 
actually into the semi starvation mode and lower the resting energy expenditure? 
One such signal is leptin, which has two functions. One function is as a pleiotropic hormone 
that relays information about peripheral energy storage and availability to the brain (Kumar et al. 
2010). Its complete role as both a starvation and satiety hormone is illustrated in Figure 1. Leptin is a 
lipoprotein, which can pass the blood-brain barrier. It is made by adipose cells and inhibits the 
production of fat and increases the individual’s physical activity potential. Leptin is twice as high in 
human beings that are obese, and this is related to their fat mass and high rate of leptin production by 
the body. 
 
 
 
 
Figure 1: Cycle of Leptin production 
in the body. Source: Friedman 2009 
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This figure shows that an increase in body weight also increases the amount of leptin produced. 
Leptin then crosses over the blood brain barrier and inhibits the brain, which leads to a decrease in food 
intake of the body. Once synthesized, leptin is secreted through a constitutive pathway and not stored in 
the cell. Chan and his colleagues (2005) describe leptin as a 167 amino acid protein product of the ob 
gene that was discovered in 1994 through positional cloning in the ob/ob obsese mouse, a model of 
morbid obesity resulting from the absence of leptin due to a gene mutation. It is secreted in a pulsatile 
fasion and has a substantial diurnal variation with an increase of about 50 percent in the late evening 
and early morning hours that might be related to an intrinsic circadian component, meal timing, and the 
sleep-wake cycle. The original study and research was conducted using mice as illustrated in Figure 2. 
Severely obese mice were observed and discovered to have a mutation that did not allow them to 
produce the leptin hormone. When artificial leptin was administered, the mice began to slim down. 
 
 
Figure 2: The Effect of leptin on body weight changes in C57BL/6J (control) and ob/ob (leptin-
deficient) mice. Source: Claycombe et al. 2008  
 
 
 
 
 
 
Schematic illustrations show of the effect of leptin on body weight changes ob/ob (leptin-
deficient) mice. Mice were weighed at day zero before the start of leptin and saline injection. Body 
weight measurements were gathered daily for the next seven days, and the amount of leptin injected 
was adjusted accordingly. The mean values were calculated by averaging daily body weight differences 
for each mouse for all groups. Leptin treatment occurred over the span of seven days. As shown, the 
bar with letter a is significantly different from the control group. The bars with letter b are significantly 
different from the obese group. The hypothesis was that this satiety hormone could be a possible 
treatment of individuals suffering from obesity. Because individuals with anorexia do not eat proper 
meals and are on an incorrect cycle, leptin levels can be severely affected as well. However, 
researchers realized how complex, not only obesity is, but leptin as well. When studying obese 
individuals, they found that many had enough leptin. The theory was that although these obese 
individuals had enough leptin to signal their hypothalamus that they are not hungry, the body did not 
perceive the proper amounts of the hormone due to a default in their receptors. Therefore, leptin is not 
C, control; O, obese; OL, obese with leptin treatment; CL, control with leptin treatment 
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the key to unlocking the mystery of causation and treatment of obesity. Although this theory proved to 
have some faulty hypothesis, the discovery of leptin is vital in the study of weight and anorexia as a 
disorder and its role as a satiety and starvation hormone. It was realized that leptin might be more 
important at the other end of the energy homeostasis spectrum, i.e. energy deprivation. In this context, 
studies in mice, as well as people, have shown that leptin has a role in the neuroendocrine adaptations 
to starvation which includes changes in hormone concentration that have a protective effect for patients 
with anorexia. Energy deficient conditions such as anorexia reflect low leptin levels, which could play 
a vital part in their pathophysiology ad potentially their treatment. 
Leptin is initially produced by the adipose tissue and is secreted into circulation. It crosses the 
blood-brain barrier with the help of a transporter protein to bind to leptin receptors in the arcuate 
nucleus of the hypothalamus (Blows 2011). The nervous and endocrine systems act together to 
coordinate functions of all body systems as illustrated in Figure 3. The endocrine system helps regulate 
virtually all types of body cells. For many years, the pituitary gland, or hypophysis, was thought to be 
the master endocrine gland because it secretes several hormones that control other endocrine glands. 
We now know that the pituitary gland has a grand master as well: the hypothalamus. This small region 
of the brain below the thalamus is the major link between the nervous and endocrine systems. 
At the point when the body mass index hits below 17.5, leptin signals the hypothalamus to go 
into semi-starvation mode.  Three main brain axes are affected by the semi-starvation mode: the 
hypothalamus-pituitary-gonadal, hypothalamus-pituitary adrenal, and hypothalamus-pituitary thyroid 
axis.  The metabolism slows down, and the first system that is shut down is the reproductive system. 
 
  
147
Udy Tropp 
 
 
Figure 3: Energy balance is regulated through complex interactions of factors in the body and the brain 
among which the hormone leptin plays an essential role. Source: Hofbauer & Huppertz 2002 
 
 
 
Figure 3 illustrates leptin and energy balance. Leptin is encoded by the Ob gene, which is 
expressed in white adipose tissue.  Leptin is similar in structure to cytokines, which are heterogeneous 
group of endogenous, bioactive peptides released mainly from inflammatory tissue and cells of the 
immune system. It is secreted into the blood and crosses the blood-brain barrier, probably via a carrier 
system which has a limited maximum transport system. In the hypothalamus, leptin acts on specific 
receptors of the class I cytokine receptor subtype. Through stimulatory or inhibitory effects on 
downstream effector systems, leptin reduces appetite. However, in its semi starvation mode, it also 
influences various endocrine systems, such as adrenocortical and gonadal hormones. In the long term, 
decreased food intake leads to a reduction in adipose tissue and consequently a diminished production 
of leptin, which then increases food intake. The fourth criterion of the DSM-IV is met when the body 
enters amenorrhea.   Like a domino effect, energy becomes more and more scarce throughout the body, 
triggering numerous hormonal cascades. Each cascade hits a specific axis. However, each cascade 
works along the same series of steps. The initial trigger is hypoleptimia, which will signal the 
hypothalamus to secrete either a releasing or inhibitory hormone. Each axis will react differently and, 
therefore, need a different type of hormone. At this point, the pituitary gland will release a specific 
hormone. Although the hormone will differ at each axis, its ultimate result will remain the same. This 
releasing hormone will trigger a specific endocrine gland to secrete yet another hormone, which will 
directly affect one of the critical homeostatic ranges of the body. This is turn will disrupt one of the 
vital metabolic processes that keep the organism alive. The same initial trigger, leptin, and ultimately 
the same devastating results (having affected homeostatic ranges) are observed. 
The first axis cascade, of the hypothalamic-pituitary gonadal axis, begins by a state of hypoleptimia, 
and this causes a reduction in gonadotropic-releasing hormones (the inhibitory hormone secreted by the 
hypothalamus). At the same time, there is sequential reduction in the follicle stimulating hormone 
(FSH) and luteinizing hormone (LH), which is normally secreted by the anterior pituitary. The 
luteinizing hormone is responsible for the ovarian-follicle growth that leads to ovulation.  With the 
reduction of the ovarian function, ovulation and reproductive functions cease, including menstruation 
(Usdan et al. 2008).  Estrogen is a key factor in ovulation because the amount must reach a certain level 
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for ovulation to be triggered. Without enough estrogen, ovulation will not occur. Estrogen levels 
decrease dramatically in women with anorexia nervosa because one of the components of estrogen is 
cholesterol, which is derived from fat. With little to no fat being consumed in one’s diet, there are 
simply not enough raw materials to create the necessary estrogen. 
Any factor causing an organism’s condition to waver away from homoeostasis can be 
interpreted as stress.  In such instances an organism’s fight or flight response recruits the body’s energy 
stores and focuses attention to overcome the challenge at hand; thus, stress throws off nearly all the 
homeostatic ranges in the body. Cortisol is one of the stress hormones produced in high levels as a 
result of severe caloric restriction, and it helps the body manage stress when a person is in semi-
starvation mode.  Cortisol, which is produced by the adrenal gland, metabolizes fat and sugar into 
energy as its primary function.  Anorexia catapults the body into starvation mode, and the body 
interprets a shift of homeostatic ranges as extreme stress.  Cortisol levels spike, and the body shifts to 
fight or flight mode to survive. This leads into the second hormonal cascade. 
The hypothalamic-pituitary-adrenal axis is affected next. As glucose becomes scarcer with the 
continued severe restriction of carbohydrates, the hypothalamus triggers a rise in corticotropin-
releasing hormone (CRH) which, in turn, triggers the pituitary to increase adrenocorticotropic hormone 
(ACTH) secretion.   This raises the cortisol levels of the adrenal gland.  At this point, the autonomic 
nervous system takes over, particularly the sympathetic portion, shifting from voluntary to involuntary, 
and the fight or flight response becomes activated.  As this is occurring, the rising level of cortisol 
triggers lipolosis and gluconeogenesis.  Any other available raw materials that are not specifically 
carbohydrates are converted into glucose to provide energy from the body to survive. The first step the 
body takes is moderate, using raw materials other than carbohydrates to maintain the energy required.  
As the disease progresses and there is less raw material available, the body begins to consume itself 
(i.e. muscles) in a further attempt to keep homoeostatic ranges and the essential body systems running. 
The rising cortisol level and the semi-starvation state elicit a response from the hypothalamic-
pituitary-thyroid axis, the third main brain axis. The thyrotropin-releasing hormone (TRH) from the 
hypothalamus is decreased, prompting a decrease in the thyroid-stimulating hormone (TSH) from the 
pituitary gland.  This, in turn, decreases the release of T3 and T4 and the overall function of the 
thyroid. This is significant because while most hormones require specific receptors within cells to 
affect them, the thyroid gland produces hormones that can interact and affect almost every cell in the 
body. While thyroid irregularity is not fatal, it does throw the body into disarray. The patient cannot 
sustain health because thyroid hormones contribute to so many important physiological processes, such 
as development, growth, and metabolism. Because of this hypothyroidism, the whole metabolic rate is 
lowered and can go into hypothermia.  Since the appetite cannot be appropriately controlled, glucose 
will not be absorbed properly, as hypothyroidism mimics the exact initial symptoms of anorexia (i.e. 
lack of food intake).  At this point, hypothyroidism is a symptom of a progression of the disease. 
As discussed, the body initially attempts moderate measures to continue its upkeep, regardless 
of the severe decrease of nutrition, and eventually moves on to more radical measures. Reproduction 
activity ceases and the body begins inhibiting production of hormones responsible for growth 
stimulation, focusing on increasing hormones that help maintain bone, tissue, and muscle already 
present. The body attempts to preserve the raw materials it already possesses. An example of this is that 
the body decreases the production of insulin-like growth factors which are responsible for the 
promotion of cell proliferation. Insulin-like growth factor is thought to be a primary growth factor and 
is required to achieving maximal growth. In contrast, there is a significant increase in growth hormone, 
which is a peptide hormone that stimulates regeneration in humans .One of the functions of the growth 
hormone is to help maintain muscle and bone mass of the adult body. It promotes healing of injuries 
and tissue repair. It also helps convert all reserves other than glucose, such as fats and amino acids into 
energy the body can use to survive. 
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Bone mass is lost early on in the course of the disorder. The body's desperate attempt for 
survival causes it to shut down bone formation, in order to conserve its small energy reserve. The 
body's desperate attempt for survival causes it to shut down bone formation, in order to conserve its 
small energy reserve. “Recently bone has been recognized as a highly metabolic tissue requiring energy 
such that new bone formation is appropriately suppressed with inadequate nutrition” (Sum et al. 2011). 
Until the point of decreased bone mass, with proper refeeding, the negative cascade of biological 
disarray wreaked on the body by starvation is reversible. Decreased bone mass, however, is a 
permanent loss, as bone cannot replenish itself. Bone regeneration is an active area of research. This 
impact of cessation of bone formation has an especially devastating effect on adolescents with 
anorexia. Anorexia patients, regardless of age, often have a very early onset of osteopenia, and as high 
as 25% of the patients develop osteoporosis. The body is now focused on trying to maintain a 
homeostatic range of calcium to keep the normal metabolic processes operating. Bone health in a 
normal, healthy adult is maintained through bone remodeling, which occurs in two phases: bone 
formation and bone resorption. Both are necessary to maintain health calcium homeostasis. Bone 
formation causes calcium to be extracted from the blood and uses it to form new bone. Bone resorption 
is when the body breaks down bone to extract the calcium needed for other body functions, such as 
neurotransmission. “Women with anorexia have increases in markers of bone resorption with decreases 
in markers of bone formation” (Sum et al. 2011). Not only is new formation not occurring, but bone is 
being broken down constantly for the needed calcium. This leads to extremely porous bones. Any 
slight tap can lead to fractures, so much so that it can be a cause of “sevenfold increases incidence of 
spontaneous fractures” (Hebebrand et al. 2007). Estrogen is also essential to bone formation, and with 
the drastically reduced levels, as previously mentioned, it maintains the state of bone resorption and 
cannot begin bone formation. This point is illustrated in menopausal women. They have a very high 
rate of osteoporosis due to their natural drastic decrease of estrogen. 
As calcium levels drop significantly in anorexics, neurotransmitter releases drop tremendously 
as well. Serotonin (a key neurotransmitter) production drops significantly. Levels also fall because 
serotonin is synthesized from carbohydrates that we intake through our diets. Since there are not 
enough raw materials to create the hormone, it is not present. As a result of serotonin deficiency, the 
individual feels satiated without eating the proper amount of food.  This is a transformation in which 
anorexics no longer control their food intake purely by choice. It becomes a physical condition in 
which, as opposed to ignoring messages and feelings of hunger their bodies send them, they really are 
not hungry. As the disease progresses, the amygdala and hypocampus of the limbic system atrophy. 
Emotions are now affected and biology takes over even the emotional aspect of food and eating. 
Memory and feelings about food, which effect how much and what a person chooses to eat, are 
distorted and they no longer can make proper choices. A complex and life-threatening physical 
problem has taken over. 
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Figure 4: Body Moving from Hypoleptinaemia to Hyperleptinaemia. Source: Matarese et al. 
 
 
 
 
 
In traditional treatment, the first step is hospitalization and refeeding, usually force-feeding.  An 
important initial step, however, is a blood test to check leptin levels. This is important because the 
degree of hypoleptinaemia in acute anorexia nervosa is an indicator of the severity of the disorder; thus, 
pronounced hypoleptinaemia is not only indicative of an exceedingly low fat mass, but also reveals that 
the neuroendocrine adaptation to semi-starvation has maximally progressed in such critically ill 
patients (Hebebrand et al. 2007). As the refeeding process progresses, the leptin levels are going to 
move from hypoleptinaemia (starvation hormone) to hyperleptinaemia (satiety hormone) as depicted in 
Figure 4. 
During the course of a normal pattern of life in a person without anorexia, leptin levels 
constantly fluctuate, but within certain limits. The danger of refeeding is that the levels move from zero 
to 60 in a very short period. The leptin in the anorexic patients have become a satiety hormone, and 
biologically, the patients cannot eat because they feel full. This is yet another example of the disease 
and treatment being biologically based. In spite of all the therapy patients receive, if they are not 
hungry, they cannot force down the food. To prevent this issue, doctors should begin refeeding 
extremely slowly, i.e. moving from 600 up to 700 calories a day, as opposed to the normal 1800 
calories. Another danger of refeeding too quickly is throwing the person’s electrolytes out of balance 
because of drastic fluid shifts, which can cause cardiac arrhythmia. Furthermore, introducing too many 
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carbohydrates very quickly is problematic because it creates a large influx of insulin and “the 
introduction of insulin to the starved system poses a variety of severe hemodynamic and electrolyte 
consequences…. The sodium retention caused by increased insulin levels can lead to hypervolemia and 
resultant cardiac and respiratory failure” (Usdan et al. 2008). 
The leptin levels should be monitored several times a day, particularly after meals, to ensure 
that they are increasing but not dramatically into a state of hyper (which causes its own set of biological 
problems). The leptin levels will also tell the doctors how soon they can introduce more calories as well 
as how much they should be increasing the caloric intake at each interval, i.e. if moving from 600 to 
750 calories produced a dramatic increase in leptin, it should perhaps be reduced to 700. 
Moreover, small amounts of leptin should also be artificially given to patients with anorexia to 
slowly bring up their levels. The purpose is twofold. The first reason is to stop the cascade; it will fool 
the body into thinking that it is not in a semi-starvation state, and the other reactions, i.e. bone loss and 
amenorrhea, will not be triggered. If leptin levels are monitored properly, i.e. given artificially when 
necessary and used to dictate refeeding amounts and schedules, it can take about six months or more to 
normalize and stabilize their leptin levels. That will allow the patient’s biological condition to improve 
dramatically by stopping many of the processes that began because of extremely low levels, i.e. 
hypothyroidism. If the leptin is introduced prior to the domino-like effects produced by the semi-
starvation and before resting energy expenditure levels drop, the underlying psychological causes of 
anorexia can be addressed, as opposed to dealing with the near death physical conditions and 
complications of the disease. Once the refeeding process is near completion and normal body mass 
index and body fat ranges are attained, leptin levels must still be monitored closely. This is important to 
ensure that leptin transitions from the energy expenditure regulator role caused by anorexia and semi-
starvation back into the satiating hormone of a healthy body. Additionally, research has shown that for 
the first six months, leptin levels in anorexia patients that have achieved a proper and healthy weight 
are often higher than people with normal, healthy weights and eating habits. Consequently, the leptin, 
in the satiety position, can hinder their weight maintenance because of this false feeling of fullness. 
(Hebebrand et al. 2007) 
Due to the importance of leptin and the information that it provides in diagnosis, treatment, and 
prevention, it can be argued that determination of leptin levels should be included in the DSM-IV as 
part of the criteria for anorexia nervosa (American Psychiatric Association 2000). Hypoleptinaemia is 
integral in diagnosing how far the disease has progressed and what form of treatment is needed. It is 
believed that if doctors use leptin levels properly to diagnose and treat patients with anorexia, mortality 
rates can and should decrease. 
CONCLUSION 
All body systems are affected by anorexia nervosa in a nearly domino-like effect. Severe 
malnutrition can ultimately lead to multi-organ failure and death. The psychiatric causes of the disease 
are likely to be impossible to address while a patient is extremely physically ill and in danger of losing 
his or her life. Physical reactions from increased leptin and serotonin levels in the body create a 
situation in which the patient no longer feels hungry. Thus, a truly effective cure for anorexia nervosa 
must take far more expertise that can be provided by a psychiatrist alone. Various medical 
professionals, in addition to mental health professionals, must work together to provide care in their 
individualized specialties in order to bring about an effective and lasting cure for this destructive and 
multifaceted disease. Where damage has been caused by the onset of anorexia nervosa, doctors must 
work together to ensure that these conditions do not continue to deteriorate, as well as work to improve 
them. Doctors must have a coordinated plan in order to truly cure the disease and ensure that the patient 
does not relapse into a state of malnutrition and disease. The false assumption of anorexia as a purely 
psychiatric condition has contributed to a fairly high mortality rate. Although anorexia is rooted in 
mental illness, its profound physiological ramifications must be dealt with first in a bottom up 
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approach.  It is only after a biological cure is effected can the road be paved to successful psychological 
counseling.  It is hypothesized that with more research on the biological basis of the disorder and 
treatment, particularly the role of leptin in diagnosing and treating this harrowing disorder, the 
mortality rates can be significantly reduced, and a greater understanding of anorexia nervosa can be 
achieved. 
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